BRPI0812346A2 - Toxina netb clostridial - Google Patents

Toxina netb clostridial

Info

Publication number: BRPI0812346A2
Authority: BR; Brazil
Prior art keywords: clostridial; netb toxin; netb; toxin; clostridial netb
Prior art date: 2007-06-08

Application number

BRPI0812346-2A2A

Other languages

English (en)

Inventor

Robert John Moore

Julian Ian Rood

Anthony Leslie Keyburn

Original Assignee

Australian Poultry Crc Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-08

Filing date

2008-06-06

Publication date

2015-01-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40093085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0812346(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-06-06 Application filed by Australian Poultry Crc Pty Ltd filed Critical Australian Poultry Crc Pty Ltd

2015-01-27 Publication of BRPI0812346A2 publication Critical patent/BRPI0812346A2/pt

2019-01-22 Publication of BRPI0812346B1 publication Critical patent/BRPI0812346B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

BRPI0812346A 2007-06-08 2008-06-06 célula hospedeira, método para a produção de um polipeptídeo isolado, composição, vacinas, método de atenuação da virulência de uma bactéria, método para determinar se um indivíduo foi exposto a um patógeno e uso da célula hospedeira, das vacinas ou da bactéria BRPI0812346B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94285807P	2007-06-08	2007-06-08
PCT/AU2008/000813 WO2008148166A1 (en)	2007-06-08	2008-06-06	Clostridial toxin netb

Publications (2)

Publication Number	Publication Date
BRPI0812346A2 true BRPI0812346A2 (pt)	2015-01-27
BRPI0812346B1 BRPI0812346B1 (pt)	2019-01-22

Family

ID=40093085

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0812346A BRPI0812346B1 (pt)	2007-06-08	2008-06-06	célula hospedeira, método para a produção de um polipeptídeo isolado, composição, vacinas, método de atenuação da virulência de uma bactéria, método para determinar se um indivíduo foi exposto a um patógeno e uso da célula hospedeira, das vacinas ou da bactéria

Country Status (14)

Country	Link
US (1)	US8263088B2 (pt)
EP (2)	EP2980100A1 (pt)
JP (2)	JP5901115B2 (pt)
CN (1)	CN101903399B (pt)
AU (1)	AU2008258277B2 (pt)
BR (1)	BRPI0812346B1 (pt)
CA (1)	CA2689302C (pt)
ES (1)	ES2550685T3 (pt)
HU (1)	HUE025717T2 (pt)
MX (1)	MX2009012924A (pt)
PL (1)	PL2164862T3 (pt)
PT (1)	PT2164862E (pt)
RU (1)	RU2474587C2 (pt)
WO (1)	WO2008148166A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2391640B1 (en) *	2009-01-30	2014-05-14	Intervet International B.V.	A clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
WO2011113801A1 (en) *	2010-03-16	2011-09-22	Universiteit Gent	Use of clostridium perfringens strain 23 to protect against necrotic enteritis
GB201118394D0 (en)	2011-10-25	2011-12-07	Univ Exeter	Vaccine
US10174086B2 (en)	2011-10-25	2019-01-08	University Of Exeter	Vaccine
KR101293667B1 (ko)	2011-11-16	2013-08-07	대한민국	닭의 괴사성 장염을 예방하는 백신 조성물
WO2013144636A1 (en)	2012-03-29	2013-10-03	University Of Exeter	Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
US9493519B2 (en) *	2012-05-23	2016-11-15	University Of Guelph	Toxin in type A Clostridium perfringens
GB201322463D0 (en) *	2013-12-18	2014-02-05	Univ Exeter	Composition
US9505810B2 (en)	2014-08-22	2016-11-29	University Of Guelph	Toxins in type A Clostridium perfringens
EP3112474A1 (en) *	2015-06-29	2017-01-04	Evonik Degussa GmbH	Method of detecting avian necrotic enteritis
WO2018206690A1 (en) *	2017-05-12	2018-11-15	Evonik Degussa Gmbh	Method for detecting c. perfringens induced diseases in animals
KR20200006108A (ko) *	2017-05-12	2020-01-17	에보니크 오퍼레이션즈 게엠베하	동물에서 씨. 퍼프린젠스 유발된 질환을 검출하는 방법
EP3630800A4 (en) *	2017-05-31	2021-03-24	Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food	VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY
CA3092519A1 (en)	2018-03-02	2019-09-06	Evonik Operations Gmbh	In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin
MX2020012669A (es) *	2018-05-29	2021-02-09	Evonik Operations Gmbh	Procedimiento in vitro para monitorear la carga de patogenos en una poblacion animal.
CN112236533A (zh) *	2018-06-15	2021-01-15	赢创运营有限公司	早期检测禽种群中坏死性肠炎爆发的方法
WO2020035741A2 (en) *	2018-07-05	2020-02-20	Novobind Livestock Therapeutics Inc.	Antibodies against disease causing agents of poultry and uses thereof
EP3894863B1 (en)	2018-12-14	2022-11-23	Evonik Operations GmbH	In vitro method for detecting avian intestinal dysbiosis
KR102207354B1 (ko) *	2019-09-02	2021-01-27	(주)제이비바이오텍	CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 닭의 괴사성장염 백신
US11381146B2 (en)	2019-09-04	2022-07-05	Nti Ag	Drive device having a tubular linear motor and a stainless steel casing
CN113717292B (zh) *	2021-09-27	2023-04-21	华中农业大学	一种针对鸡坏死性肠炎的融合蛋白疫苗及其制备方法
CN116284281B (zh) *	2023-03-07	2025-10-03	广东省农业科学院动物卫生研究所	G型产气荚膜梭菌的重组蛋白、疫苗及应用
WO2026017094A1 (zh) *	2024-07-16	2026-01-22	成都今是科技有限公司	核酸测序系统

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2413974A1 (fr)	1978-01-06	1979-08-03	David Bernard	Sechoir pour feuilles imprimees par serigraphie
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US4945050A (en)	1984-11-13	1990-07-31	Cornell Research Foundation, Inc.	Method for transporting substances into living cells and tissues and apparatus therefor
US4676980A (en)	1985-09-23	1987-06-30	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Target specific cross-linked heteroantibodies
WO1987006614A1 (en)	1986-04-30	1987-11-05	Boyce Thompson Institute For Plant Research, Inc.	Electric field mediated dna transformation of plant cells and organelles
US5177010A (en)	1986-06-30	1993-01-05	University Of Toledo	Process for transforming corn and the products thereof
US4903635A (en)	1986-07-02	1990-02-27	Embrex, Inc.	High speed automated injection system for avian embryos
SE455438B (sv)	1986-11-24	1988-07-11	Aga Ab	Sett att senka en brennares flamtemperatur samt brennare med munstycken for oxygen resp brensle
US5004863B2 (en)	1986-12-03	2000-10-17	Agracetus	Genetic engineering of cotton plants and lines
WO1991000360A1 (en)	1989-06-29	1991-01-10	Medarex, Inc.	Bispecific reagents for aids therapy
US5141131A (en)	1989-06-30	1992-08-25	Dowelanco	Method and apparatus for the acceleration of a propellable matter
US5056464A (en)	1990-01-18	1991-10-15	Embrex, Inc.	Automated injection system for avian embryos with advanced fluid delivery system
AU8914291A (en)	1990-11-23	1992-06-25	Plant Genetic Systems N.V.	Process for transforming monocotyledonous plants
US5384253A (en)	1990-12-28	1995-01-24	Dekalb Genetics Corporation	Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
EP0586505A1 (en)	1991-05-14	1994-03-16	Repligen Corporation	Heteroconjugate antibodies for treatment of hiv infection
US5136979A (en)	1991-09-25	1992-08-11	Embrex, Inc.	Modular injection system for avian embryos
WO1993008829A1 (en)	1991-11-04	1993-05-13	The Regents Of The University Of California	Compositions that mediate killing of hiv-infected cells
US5643578A (en)	1992-03-23	1997-07-01	University Of Massachusetts Medical Center	Immunization by inoculation of DNA transcription unit
WO1993021335A2 (en)	1992-04-15	1993-10-28	Plant Genetic Systems, N.V.	Transformation of monocot cells
DK0639640T3 (da)	1993-07-30	2001-01-02	Akzo Nobel Nv	Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
EP1170368B1 (en)	1994-01-27	2010-07-28	University Of Massachusetts Medical Center	Immunization by inoculation of dna transcription unit
ES2174027T3 (es) *	1995-06-30	2002-11-01	American Cyanamid Co	Composiciones estables que contienen macrolidos y macrolidos combinados con unas vacunas.
US5792294A (en)	1995-11-16	1998-08-11	Otis Elevator Company	Method of replacing sheave liner
US5939400A (en)	1996-02-26	1999-08-17	The Board Of Trustees Of The Leland Stanford Junior University	DNA vaccination for induction of suppressive T cell response
GB9605222D0 (en) *	1996-03-12	1996-05-15	Secr Defence	Clostridium perfringens epsilon toxin vaccines
AU3210997A (en)	1996-05-24	1997-12-09	University Of Maryland At Baltimore	Dna vaccines for eliciting a mucosal immune response
DE69836520T2 (de) *	1997-06-20	2007-06-06	Intervet International B.V.	Clostridium perfringens Impfstoff
EP1023442B1 (en)	1997-10-16	2010-11-24	University Of Georgia Research Foundation, Inc.	Transgenic birds and protein production
UA78486C2 (uk) *	1999-12-10	2007-04-10	Хемджен Корпорейшн	Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
EP2380440B1 (en) *	2002-04-15	2016-03-09	Washington University	Regulated attenuation of live vaccines to enhance cross protective immunogenicity
US20040101531A1 (en) *	2002-04-16	2004-05-27	Roy Curtiss	Immunogenic compositions and vaccines comprising carrier bacteria that secrete antigens
EP1644492B1 (en) *	2003-06-18	2009-01-07	Genelux Corporation	Modified recombinant vaccinia viruses, uses thereof
US7617795B2 (en)	2004-10-13	2009-11-17	Embrex, Inc.	Methods and apparatus for injecting and sampling material through avian egg membranes
AU2006287110B2 (en)	2005-08-30	2012-04-12	Commonwealth Scientific And Industrial Research Organisation	Bacterial delivery of biologically active polypeptides
RU2409385C2 (ru) *	2006-03-30	2011-01-20	Эмбрекс, Инк.	Способ иммунизации птицы против инфекции, вызванной бактериями clostridium
US9040059B2 (en) *	2007-10-05	2015-05-26	The Arizona Board Of Regents For And On Behalf Of Arizona State University	Recombinant bacterium capable of eliciting a protective immune response against C. perfringens

2008
- 2008-06-06 BR BRPI0812346A patent/BRPI0812346B1/pt active IP Right Grant
- 2008-06-06 EP EP15177663.0A patent/EP2980100A1/en not_active Withdrawn
- 2008-06-06 CN CN200880019023.XA patent/CN101903399B/zh active Active
- 2008-06-06 HU HUE08756897A patent/HUE025717T2/en unknown
- 2008-06-06 WO PCT/AU2008/000813 patent/WO2008148166A1/en not_active Ceased
- 2008-06-06 RU RU2009149378/10A patent/RU2474587C2/ru active
- 2008-06-06 PL PL08756897T patent/PL2164862T3/pl unknown
- 2008-06-06 PT PT87568978T patent/PT2164862E/pt unknown
- 2008-06-06 ES ES08756897.8T patent/ES2550685T3/es active Active
- 2008-06-06 CA CA2689302A patent/CA2689302C/en active Active
- 2008-06-06 MX MX2009012924A patent/MX2009012924A/es active IP Right Grant
- 2008-06-06 JP JP2010510616A patent/JP5901115B2/ja active Active
- 2008-06-06 AU AU2008258277A patent/AU2008258277B2/en active Active
- 2008-06-06 US US12/663,215 patent/US8263088B2/en active Active
- 2008-06-06 EP EP08756897.8A patent/EP2164862B1/en active Active
2014
- 2014-06-12 JP JP2014121284A patent/JP2014221046A/ja active Pending

Also Published As

Publication number	Publication date
CA2689302C (en)	2015-08-25
JP2010529838A (ja)	2010-09-02
EP2164862B1 (en)	2015-07-22
CN101903399A (zh)	2010-12-01
AU2008258277A1 (en)	2008-12-11
PL2164862T3 (pl)	2015-12-31
EP2164862A4 (en)	2011-11-02
ES2550685T3 (es)	2015-11-11
US8263088B2 (en)	2012-09-11
WO2008148166A1 (en)	2008-12-11
JP2014221046A (ja)	2014-11-27
US20100291131A1 (en)	2010-11-18
MX2009012924A (es)	2010-03-25
CA2689302A1 (en)	2008-12-11
RU2474587C2 (ru)	2013-02-10
JP5901115B2 (ja)	2016-04-06
RU2009149378A (ru)	2011-07-20
PT2164862E (pt)	2015-10-29
EP2164862A1 (en)	2010-03-24
BRPI0812346B1 (pt)	2019-01-22
EP2980100A1 (en)	2016-02-03
AU2008258277B2 (en)	2012-07-12
CN101903399B (zh)	2014-09-10
HUE025717T2 (en)	2016-04-28

Publication	Publication Date	Title
BRPI0812346A2 (pt)	2015-01-27	Toxina netb clostridial
IL281675A (en)	2021-05-31	Injectable botulinum toxin formulations
BRPI0816771A2 (pt)	2015-03-24	Espaçador interespinhal
PL2419441T3 (pl)	2015-06-30	Owadzie toksyny Cry obejmujące DIG-3
FI20085597L (fi)	2009-12-18	Tiedon haku
DE602008003603D1 (de)	2011-01-05	Speicherplattensystem
HRP20170963T1 (hr)	2017-09-22	Modificirani saharidi
EP2145362A4 (en)	2012-01-25	DATA PROCESSING INFRASTRUCTURE
DE602008002287D1 (de)	2010-10-07	Aufzeichnungsgerät
BRPI0819600A2 (pt)	2015-05-05	Servoválvula.
DE602008002037D1 (de)	2010-09-16	Aufzeichnungsgerät
FI7604U1 (fi)	2007-08-09	Tuntoelin
HK1142614A (en)	2010-12-10	Clostridial toxin netb
EP2202304A4 (en)	2010-11-24	MODIFIED CREATININE AMIDOHYDROLASE
FR2920806B1 (fr)	2010-11-12	Cadenas.
ES1065818Y (es)	2008-06-01	Picaporte magnetico
FI20075839A0 (fi)	2007-11-26	Tietojärjestelmä
ITCO20060012A1 (it)	2006-06-29	Anti - urto
SE0702505L (sv)	2009-05-15	Smart dust
FI20085818A0 (fi)	2008-09-02	Informaatiojärjestelmä
FI20085559A0 (fi)	2008-06-05	Informaatiojärjestelmä
FI20070088A0 (fi)	2007-02-02	Haaviston luomu-arkku
ES1066176Y (es)	2008-03-16	Mueble publicitario
UA17262S (uk)	2008-09-10	Цінник
UA16352S (uk)	2008-04-25	Музичний автомат

Legal Events

Date	Code	Title	Description
2017-02-21	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2017-10-03	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2018-11-13	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-01-22	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/01/2019, OBSERVADAS AS CONDICOES LEGAIS.